Selasa, 09 Juni 2026 - 20:33 WIB

Find and Follow Us

Global Markets

IHSG 5,746.65 +7.57%

S&P 500 7,446.49 +0.55%

NASDAQ 25,929.66 +0.00%

Dow Jones 50,937.00 +0.30%

FTSE 100 10,335.53 -0.36%

CAC 40 8,272.42 +0.89%

Nikkei 225 65,416.63 +2.17%

Hang Seng 24,565.90 -0.37%

Shanghai 4,010.03 +1.28%

KOSPI 8,096.93 +8.18%

STI 5,023.25 +1.20%

ASX 200 8,604.20 -0.24%

Sensex 73,918.76 +0.54%

Gold 4,358.50 +0.52%

Silver 68.56 +0.20%

Oil (WTI) 88.94 -2.58%

Brent 92.25 -2.12%

Copper 6.44 +1.71%

Gas Alam 3.15 +0.00%

Bitcoin 62,295.90 -1.26%

Ethereum 1,669.53 -1.22%

USD/IDR 18,050.00 +0.12%

EUR/USD 1.16 +0.46%

Advertisement

Kalbe Farma kembangkan Penelitian Jamur anti virus (Kontan)

Kinerja Industri Farmasi Nasional PT Kalbe Farma Tbk Moncer, Siapkan Dividen Rp937,5 Miliar

Redaksi • 18 Mei 2020

Latest Updates

- Advertisement -

Kalbe Farma kembangkan Penelitian Jamur anti virus (Kontan)

18:15 WIB • 18 Mei 2020

Kinerja Industri Farmasi Nasional PT Kalbe Farma Tbk Moncer, Siapkan Dividen Rp937,5 Miliar

Emiten farmasi PT Kalbe Farma Tbk (KLBF) akan membagikan dividen tunai sebesar Rp937,5 miliar berdasarkan hasil Rapat Umum…